Given the predictability of dental implant success, the attention of the scientific community is moving from descriptions of implant success toward a more detailed analysis of factors associated with implant failure. The purposes of this study were (1) to estimate the 1-and 5-year survival of Bicon dental implants and (2) to identify risk factors associated with implant failure in an objective, statistically valid manner. To address the research purposes, we used a retrospective cohort study design and a study sample composed of patients who had one or more implants placed. The predictor variables were grouped into the following categories: demographic, health status, anatomic, implant fixturespecific, prosthetic, perioperative, and ancillary variables. The major outcome variable of interest was implant failure defined as implant removal. Overall implant survival was estimated using the Kaplan-Meier analysis. Risk factors for implant failure were identified using the Cox proportional hazard regression models. The study sample was composed of 677 patients who had 677 implants randomly selected for analysis. The overall 1-and 5-year survival of the Bicon implant system was 95.2% and 90.2%, respectively. After adjusting for other covariates in a multivariate model, both tobacco use (P ϭ .0004) and single-stage implant placement (P ϭ .01) were statistically associated with an increased risk for failure. The results of these analyses suggest that the overall survival of the Bicon dental implant is comparable with other current implant systems. In addition, after controlling for covariates, we identified 2 exposures associated with implant survival, tobacco use and implant staging. Of interest, both of these exposures are under the clinician's control.
INTRODUCTION
O ver the last 20 years, endosseous dental implants have become a predictable procedure to facilitate the prosthetic replacement of teeth. Due to the remarkable success of dental im-plants, there is a growing interest in identifying factors associated with implant failure. The scientific literature regarding the risk factors for implant failure is limited. As such, Esposito et al concluded that the ''. . . treatment of biologic complications and failing im-plants lacks systemic scientific validation and is based mainly on empirical experience and inference from in vitro findings on a trial-and-error basis.'' 1 We conducted a literature review designed to identify publications that addressed implant survival and factors affecting survival. The published literature on this topic is voluminous and beyond the scope of this article to summarize completely. To focus the review, we used the University of Rochester search filters available from OVID (Ovid Technologies, Inc, New York, NY) to identify the papers addressing prognosis (implant failure) and etiology (risk factors) of implant failure. For the prognosis papers, we limited the search to articles using prospective study designs with survival or Kaplan-Meier analyses and having more than 1 year of follow-up. Forty-two papers met the selection criteria. The mean survival for dental implants at 1 year ranged from 73.8% to 100.0%. The mean 5-year survival ranged from 85.6% to 100.0%. To identify papers related to risk factors, we limited the search to reports using prospective study design with proportional hazards analyses and more than 50 implants. This search strategy produced a list of 19 citations that were reviewed in detail. Multiple variables were identified as factors that increased the risk for implant failure, and we categorized them as follows: (1) demographic variables, which included gender and age at time of implant placement; 11, 44 (2) health-status variables, which included American Society of Anesthesia (ASA) status, medically compromised patients, tobacco use, history of periodontal disease, and prior root canal therapy in site of implant placement; 11, 28, [45] [46] [47] [48] (3) anatomic variables, which included location of implant placement, bone quality, proximity of implant relative to other teeth and implants, and number of implants per patient; 2, 18, 27, 34, 38, 45, 48, 49 (4) implant fixture-specific variables, which included small length, short diameter, and type of implant coating; 2,34,37,46,50 (5) ancillary variables, which included the timing of implant placement in patients who needed bone grafts; 51 and (6) other variables, which included lack of keratinized gingiva, poor oral hygiene, plaque accumulation, and occlusal overload. 34, 36, 52 The first specific aim of this research project was to estimate the 1and 5-year survival of Bicon (Bicon Inc, Boston, Mass) implant fixtures in an objective, independent, and statistically valid manner. The implant system under review has Food and Drug Administration (FDA) approval and is in general use nationally and internationally. 53 We hypothesized that Bicon implants would be equivalent to other implant systems in terms of overall implant survival at 1 and 5 years after placement.
The second specific aim of this research project was to identify risk factors associated with implant failures. For the purposes of this project, we chose the Bicon implant system for 2 reasons. First, the published literature documenting the clinical use and success of Bicon implants was limited. 25, 54 Morgan and Chapman reported the results of a 10-year uncontrolled retrospective analysis of 1889 implants placed and loaded in 327 patients. The overall survival estimates were 98.2% and 96.9% at one and five years after fixture placement, respectively. 54 In a 4-year prospective study of 168 patients receiving 432 Bicon implants conducted by Muftu and Chapman, the cumulative survival at the end of 4 years was 90.0% in the maxilla and 96.8% in the mandible. 25 The second reason for choosing the Bicon implant for analyses was that we had ready and unfettered access to the records of several hundred patients treated over an 8-year time period.
MATERIALS AND METHODS

Study design and sample
To address our specific aims, we used a retrospective cohort study design.
The study cohort was derived from the population of patients who had Bicon implants placed by practitioners at Implant Dentistry Centre at Faulkner Hospital (IDC-FH), Boston, Mass, between May 1992 and July 2000. All patients who had implants placed at the IDC-FH were eligible for inclusion in the study. The IDC-FH is a teaching facility. The clinicians placing implants had varying degrees of clinical implant experience, ranging from zero to many years of experience. The sample was composed of patients who had charts available for review.
Study variables
The predictor variables (risk factors or exposures) were grouped into the following categories:
1. Demographic variables: These variables included the patient's age at time of implant placement (years) and gender. 2. Health-status variables: General health status was classified using the American Society of Anesthesiology (ASA) system. 55 Patients were categorized as healthy (ASA 1), mild systemic disease (ASA 2), or moderate or severe systemic disease (ASA 3). In addition, we recorded whether the patient had a medical condition that could have compromised wound healing, such as immunosuppression or diabetes, and current tobacco use status.
Anatomic variables: The anatomic
variables included implant position (maxilla, mandible, anterior, posterior), bone quality (types 1-4), and proximity of the implant relative to other teeth or implants. For the purposes of this study, bone quality was assessed clinically at the time of implant placement. Following withdrawal of the 3.5-mm reamer from the osteotomy, the amount and appearance of bone in the flutes of the reamer was evaluated. If the bone was red and filled the flutes, the bone quality was classified as type 2. If there was no bone retained in the flutes, the bone quality was classified as type 4. Intermediate findings were classified as type 3 bone quality. Type 1 classification was reserved for compact (near bloodless) cortical bone. The relationship of the implant to other dentoalveolar structures was grouped into the following categories: no teeth (edentulous), 1 natural tooth, 2 natural teeth, 1 implant, 2 implants, and 1 natural tooth and 1 implant. 56 4. Implant fixture-specific variables:
These variables included implant size (width 3-5 mm, length 6-13 mm); implant coating (uncoated, titanium plasma sprayed [TPS], hydroxyapatite [HA]); abutment size in terms of diameter, length, and angulation; or use of a temporary implant. 5. Prosthetic variables: Prosthetic variables were grouped by restoration into 3 categories: removable (overdenture), fixed denture or bridge, or single crown. 6. Ancillary procedures: Ancillary procedures were defined as treatments designed to enhance the recipient site. Data collected included types and materials used for augmentation and timing of implant placement relative to the augmentation procedure. The types of augmentation procedures we evaluated included internal or lateral sinus lifts, barrier membranes, autologous and bone-substitute grafting, and ridge split procedures. For patients having ancillary procedures, the timing of fixture placement was grouped into 2 categories: (1) immediate (ancillary procedure and implant placed on same day) or (2) 
Outcome variables
The primary outcome variable, implant failure, was defined as removal of the implant. The duration of implant survival was computed by calculating the time between implant placement and the date of the last follow-up or implant removal. The duration of implant survival was reported in months.
Data analyses
A database was created using EpiInfo (Centers for Disease Control and Prevention, Atlanta, Ga) with appropriate checks to identify and correct errors. SAS (SAS Institute, Carey, NC) statistical software was used for the data analyses. For purposes of data analyses, to assure statistical validity, one implant was randomly selected from each patient. 4, 17, 59 Descriptive statistics were computed for all study variables. The overall 1-and 5-year survival rates with associated 95% confidence intervals were computed based on the nonparametric Kaplan-Meier survival analyses (1958). 60 Cox proportional hazards regression analyses based on the semiparametric methodology were used to identify covariates associated with survival. 61 Implant survival (primary outcome variable) was defined as the duration of time, in months, from the date of implant placement to date of implant failure (explanation). Implants that did not fail were considered censored in survival analyses. We included potentially significant predictor variables (P Ͻ .15), that is, risk factors for implant failure, based on bivariate Cox regression analyses. The multivariate Cox model was built and a parsimonious model was selected based on the likelihood ratio test and evaluation based on the biologic and near statistically significant variables (P Ͻ .15) identified using the bivariate Cox regression analyses.
The well-documented average long-term (Ͼ1 year) survival for vari-ous implants ranged from 73.8% to 100.0%. To estimate our sample size, we wanted to have 99% confidence that the overall 5-year implant survival rate is 95% Ϯ 5% (90%-100%). 62 Based on these parameters, our estimated sample size was 506 implants.
RESULTS
During the study interval, 702 patients had implants placed. Charts for 25 patients were not available for review because the patient was deceased, had moved, was inactive, could not be found in the computer, or the chart could not be found. The eligible study sample is therefore composed of 677 patients who had a total of 2349 implants placed. To assure statistical validity, 1 implant was randomly selected from each patient, resulting in a final sample for analysis consisting of 677 patients and 677 implants.
The mean age of the patients was 53.5 Ϯ 13.9 years, and 49.9% of the patients were male. Most patients (99.1%) were healthy or had mild systemic disease (ASA scores Յ 2) and 10.3% reported tobacco use at the time the implant was placed. The details of the descriptive statistics are summarized in Table 1 . The overall 1-and 5-year survival estimates with associated 95% confidence intervals were 95.2% (93.5%, 97.0%) and 90.2% (86.0%, 94.4%), respectively ( Table 2) . Table 3 summarizes the results using the Cox proportional hazards model to measure the association between the various study variables and implant failure. Two variables statistically associated with failure were tobacco use (P ϭ .007) and implant staging (P ϭ .009). Smokers and patients having 1-stage implants placed had an increased risk for implant failure compared with nonsmokers or those patients who had implants staged.
To create a multivariate model, we selected a set of variables that were either biologically important (age and gender) or were statistically associated with implant failure at P Ͻ .15. Variables meeting this latter inclusion cri- (Table 4 ).
DISCUSSION
Endosseous implant-based prostheses are successful, effective, and predictable devices for replacing missing teeth. Recently, however, the scientific literature is changing its focus from describing implant success to identifying risk factors associated with implant failure. The purposes of this study were (1) to estimate the 1-and 5-year survival of Bicon dental implants and (2) to identify risk factors associated with implant failure. In brief, the 1and 5-year survival of the Bicon implants were 95.2% (93.6%, 97.0%) and 90.2% (86.0%, 94.4%), respectively. These survival results are comparable with the mean survival for other studies' reported 1-year survival range of 73.8% to 100.0%. The mean 5-year survival of other implants ranged from 85.6% to 100.0. Based on the results of this study, after adjusting for other covariates using the Cox proportional hazards model, tobacco use (P ϭ .0004) was statistically associated with an increased risk for failure, with a hazard ratio of 4.3. One-stage implants were associated with an increased risk for failure (adjusted hazard ratio ϭ 3.0, P ϭ .01). While other studies identified various factors that were associated with implant failure that were discussed earlier, our study found that only tobacco use and staging of the implant were statistically signifi- cant. 2, 12, 19, 28, 29, 35, [37] [38] [39] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] Possible reasons why our results were different are because of our large sample size, differences in our definition of implant failure, and our method of analyzing our data through multivariate analyses instead of using univariate analyses. As clinicians, it is of interest to note that the 2 risk factors statistically associated with failure identified in this study, tobacco use and implant staging, are under the clinician's control to some extent. As such, the clinician may be in a position to modify or choose among these factors to optimize outcome. For example, tobacco use increases the risk for implant failure. The clinician can choose to place or to not place implants in tobacco users. In addition, the clinician can choose to perform 1-or 2-stage implant procedures. As always, the clinician needs to consider the patient's preferences and wishes in choosing treatment alternatives. Table 5 summarizes the effect of various combinations of tobacco use and implant staging on the estimated 1-and 5-year survival of implants using the multivariate model developed in this article. The highest survival rates are associated with nonsmokers who have implants placed in 2 stages. For this group, the 1-and 5-year survival rates, estimated from the multivariate model, were 97.1% and 92.9%, respectively. The poorest outcome is expected from smokers who undergo a single-stage implant placement procedure. For this group of patients, the estimated 1-and 5-year survival rates were 67.6% and 38.3%, respectively.
CONCLUSION
The results of these analyses suggest that the overall survival of the Bicon dental implant is comparable with other current implant systems. In addition, after controlling for other variables, we identified 2 exposures associated with implant survival. Of interest, these exposures, tobacco use and staging of implant placement, are under the control of the clinician. We would encourage other investigators to pursue research to identify factors that affect implant survival. Having better information about these risk factors will enhance the clinician's ability to choose among different treatment options while accounting for the patient's preferences and wishes in order to optimize implant treatment success.
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